INHIBITORS OF THE MENIN-MLL INTERACTION
The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction. La presente invención se dirige a inhibido...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ZANG, Linghang Chengguo DONG CLAREMON, David A VENKATRAMAN, Shankar Suresh B. SINGH Lanqi JIA Yi FAN ZHENG, Yajun YUAN, Jing |
| description | The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
La presente invención se dirige a inhibidores de la interacción de menina con MLL y proteínas de fusión de MLL, composiciones farmacéuticas que contienen los mismos, y su uso en el tratamiento de cáncer y otras enfermedades mediante por la interacción de menina-MML. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2018007703A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2018007703A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2018007703A3</originalsourceid><addsrcrecordid>eNrjZFD39PPwdPIM8Q8KVvB3UwjxcFXwdfXz9NP19fFR8PQLcQ1ydA7x9PfjYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxvhFGBoYWBgbm5gbGjsZEKQIAKhkkSg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INHIBITORS OF THE MENIN-MLL INTERACTION</title><source>esp@cenet</source><creator>ZANG, Linghang ; Chengguo DONG ; CLAREMON, David A ; VENKATRAMAN, Shankar ; Suresh B. SINGH ; Lanqi JIA ; Yi FAN ; ZHENG, Yajun ; YUAN, Jing</creator><creatorcontrib>ZANG, Linghang ; Chengguo DONG ; CLAREMON, David A ; VENKATRAMAN, Shankar ; Suresh B. SINGH ; Lanqi JIA ; Yi FAN ; ZHENG, Yajun ; YUAN, Jing</creatorcontrib><description>The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
La presente invención se dirige a inhibidores de la interacción de menina con MLL y proteínas de fusión de MLL, composiciones farmacéuticas que contienen los mismos, y su uso en el tratamiento de cáncer y otras enfermedades mediante por la interacción de menina-MML.</description><language>eng ; spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181109&DB=EPODOC&CC=MX&NR=2018007703A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181109&DB=EPODOC&CC=MX&NR=2018007703A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZANG, Linghang</creatorcontrib><creatorcontrib>Chengguo DONG</creatorcontrib><creatorcontrib>CLAREMON, David A</creatorcontrib><creatorcontrib>VENKATRAMAN, Shankar</creatorcontrib><creatorcontrib>Suresh B. SINGH</creatorcontrib><creatorcontrib>Lanqi JIA</creatorcontrib><creatorcontrib>Yi FAN</creatorcontrib><creatorcontrib>ZHENG, Yajun</creatorcontrib><creatorcontrib>YUAN, Jing</creatorcontrib><title>INHIBITORS OF THE MENIN-MLL INTERACTION</title><description>The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
La presente invención se dirige a inhibidores de la interacción de menina con MLL y proteínas de fusión de MLL, composiciones farmacéuticas que contienen los mismos, y su uso en el tratamiento de cáncer y otras enfermedades mediante por la interacción de menina-MML.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFD39PPwdPIM8Q8KVvB3UwjxcFXwdfXz9NP19fFR8PQLcQ1ydA7x9PfjYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxvhFGBoYWBgbm5gbGjsZEKQIAKhkkSg</recordid><startdate>20181109</startdate><enddate>20181109</enddate><creator>ZANG, Linghang</creator><creator>Chengguo DONG</creator><creator>CLAREMON, David A</creator><creator>VENKATRAMAN, Shankar</creator><creator>Suresh B. SINGH</creator><creator>Lanqi JIA</creator><creator>Yi FAN</creator><creator>ZHENG, Yajun</creator><creator>YUAN, Jing</creator><scope>EVB</scope></search><sort><creationdate>20181109</creationdate><title>INHIBITORS OF THE MENIN-MLL INTERACTION</title><author>ZANG, Linghang ; Chengguo DONG ; CLAREMON, David A ; VENKATRAMAN, Shankar ; Suresh B. SINGH ; Lanqi JIA ; Yi FAN ; ZHENG, Yajun ; YUAN, Jing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2018007703A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZANG, Linghang</creatorcontrib><creatorcontrib>Chengguo DONG</creatorcontrib><creatorcontrib>CLAREMON, David A</creatorcontrib><creatorcontrib>VENKATRAMAN, Shankar</creatorcontrib><creatorcontrib>Suresh B. SINGH</creatorcontrib><creatorcontrib>Lanqi JIA</creatorcontrib><creatorcontrib>Yi FAN</creatorcontrib><creatorcontrib>ZHENG, Yajun</creatorcontrib><creatorcontrib>YUAN, Jing</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZANG, Linghang</au><au>Chengguo DONG</au><au>CLAREMON, David A</au><au>VENKATRAMAN, Shankar</au><au>Suresh B. SINGH</au><au>Lanqi JIA</au><au>Yi FAN</au><au>ZHENG, Yajun</au><au>YUAN, Jing</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INHIBITORS OF THE MENIN-MLL INTERACTION</title><date>2018-11-09</date><risdate>2018</risdate><abstract>The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
La presente invención se dirige a inhibidores de la interacción de menina con MLL y proteínas de fusión de MLL, composiciones farmacéuticas que contienen los mismos, y su uso en el tratamiento de cáncer y otras enfermedades mediante por la interacción de menina-MML.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; spa |
| recordid | cdi_epo_espacenet_MX2018007703A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | INHIBITORS OF THE MENIN-MLL INTERACTION |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T09%3A09%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZANG,%20Linghang&rft.date=2018-11-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2018007703A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |